SLE: Belimumab + standard rx significantly⬇️risk of severe flares vs placebo.
Greatest in those with:
🔹+dsDNA
🔹low C3 or C4
🔹SLICC/ACR Damage index of 0 (argument for early treatment!)
https://t.co/UcGXEklqwJ
#ACR21 Abst#1295
@RheumNow
Links:
Belimumab Reduces Severe Flares in Systemic Lupus Erythematosus Across Multiple…
https://bit.ly/3mYrEiO
08-11-2021